Skip to main content

Table 2 Clinical data

From: A modified Sequential Organ Failure Assessment score for dengue: development, evaluation and proposal for use in clinical trials

 

N

All patients

Median (Q1; Q3) or n (%)

Age (years)

124

24.5 (20; 32)

Sex male

124

63 (50.8)

Comorbidities

124

9 (7.3)

Transferred from other hospital

124

74 (59.7)

BMI (kg/m2)

124

23.1 (19.9; 26.3)

Day of illness at time of shock onset

124

5 (4; 5)

ICU admission

124

29 (23.4)

 ICU length of stay (days)

29

3 (2; 5)

Hospital length of stay (days)

124

5 (4; 7)

Mechanical ventilation

124

9 (7.3)

 Length of mechanical ventilation support (days)

9

7 (4; 8)

Vasopressor support

124

8 (6.5)

 Length of vasopressor support (days)

8

3 (1.8; 4.8)

Length of IV fluid use (days)

124

2 (2; 2)

Total volume of IV fluid use (L)

124

4.7 (3.5; 6.3)

Haemofiltration

124

6 (4.8)

 Length of haemofiltration use (days)

6

5.5 (3.2; 7.0)

Death

124

5 (4.0)

  1. BMI body mass index; ICU intensive care unit; IV intravenous; Q1 first quartile (25th percentile); Q3 third quartile (75th percentile)